1 |
Motifs de régulation et dynamique de la voie Mitogen Activated Protein Kinase lors de la transition G2/M des ovocytes de Xénope / Regulation motifs and dynamic of Mitogen Actived Protein Kinase cascade during Xenopus laevis oocytes G2/M transitionBeaujois, Rémy 17 December 2010 (has links)
Lors de la transition G2/M des ovocytes de Xénope, la voie p39Mos-MEK1-MAPK présente des propriétés dynamiques et physiques particulières telles que l’ultrasensibilité, la bistabilité, l’irréversibilité et un caractère ‘tout-ou-rien’. Ces propriétés sont considérées dans le contexte de la boucle de rétroaction positive qui existe au sein de cette voie. L’objectif de cette thèse s’est focalisé sur le rôle de l’oncoprotéine p39Mos et le recrutement des motifs de régulation qui permettent l’apparition de ces propriétés. Des approches expérimentales et in silico ont été menées pour réaliser une modélisation physiquement et biologiquement réaliste de ce réseau. Le modèle développé tient compte de l’influence du MPF sur l’accumulation de p39Mos et ajuste le rôle de la boucle de rétrocontrôle positif. Par ailleurs, nous avons pu mettre en évidence que p90Rsk, cible des MAPK, est dégradée. La voie MAPK a été activée en absence de p39Mos. Nos résultats montrent que la 1,10 Phénanthroline monohydrate (1,10-PA) active les MAPK suivant une réponse graduelle et ultrasensible. L’action de la 1,10-PA s’exerce en absence de synthèse protéique et de toute boucle de rétrocontrôle, et nous avons émis l’hypothèse que la 1,10 PA agit via l’inactivation d’une MEK-phosphatase. Dans ce contexte, un modèle de pro-action est discuté et des inhibiteurs de phosphatases ont été utilisés pour activer les MAPK en absence de p39Mos. Nos résultats discutent du rôle de la boucle de rétroaction positive dans l’activation des MAPK et montrent que l’ultrasensibilité de réponse des MAPK peut être générée par des motifs de régulation de type pro-action. / During G2/M transition in Xenopus oocyte, p39Mos-MEK1-MAPK cascacade harbors specific dynamic and physical properties, such as ultrasensitivity, bistability, irreversibility, and all-or-none responses. These properties are generally considered in the context of the positive feedback loop that embeds the p39Mos-MEK1-MAPK pathway architecture. The objective of this work was focused onto p39Mos oncoprotein and regulation motifs recruitment enabling together the generation of such properties. Both experimental and in silico approaches were undertaken in order to yield a realistic modelisation, physically and biologically relevant for this network. We developed a model that takes into account the influence of MPF onto p39Mos accumulation, and adjusts the role of the positive feedback loop. Also, we were able to show that p90Rsk, target of MAPK, was degraded. This signaling pathway was activated in the absence of p39Mos. Our results show that 1,10 Phénanthroline monohydrate (1,10-PA) is able to induce gradual and ultrasensitive MAPK activation. 1,10-PA action is then exerted in the absence of protein synthesis and positive feedback loop. In this context, a feed forward loop model can be considered, and phosphatase inhibitors were used for MAPK activation in the absence of p39Mos. Our results confront the role attributed to the positive feedback loop in MAPK activation, and show that this ultrasensitive response may be generated in vivo through feed forward regulation motifs.
|
2 |
ATM/ATR-dependent responses to dysfunctional telomeres at the G2/M transitionThanasoula, Maria January 2012 (has links)
Mammalian telomeres are nucleoprotein complexes at the end of chromosomes containing a specific protein complex, called shelterin. Shelterin protects chromosome ends from the DNA damage response (DDR), by facilitating the formation of a telomeric capping structure, called the T-loop. During their elongation in S phase, telomeres become transiently uncapped and can be sensed as DNA damage in G2 phase. This leads to the recruitment of DDR factors, such as phosphorylated histone H2AX (γH2AX), to the telomeres forming the so-called, telomere dysfunction-induced foci (TIFs). My PhD work described here, indicates that DNA damage occurring during interphase can persist after entry into mitosis, indicated by the detection of γH2AX at a subset of mitotic telomeres in human and mouse cells. This accumulation of γH2AX to mitotic telomeres is ATM-dependent and the γH2AX-labelled uncapped telomeres that persist, are shorter than the average telomere length for the entire cell population. Most importantly, my work suggests that telomere uncapping, naturally occurring or artificially induced, is detected by two parallel ATM/ATR-dependent pathways at the G2/M transition: a p53/p21-dependent pathway through the ATM/ATR-mediated phosphorylation of p53 at Ser15 and a CHK1/CHK2-dependent pathway that acts through negative regulation of CDC25 phosphatases. In particular, telomere uncapping triggered by TRF2 depletion leads to CHK2-dependent CDC25A degradation, while POT1 depletion results in CHK1-mediated CDC25A and CDC25C degradation. Both pathways act as sensors of unprotected telomeres at the G2/M transition and block cell cycle progression through inhibition of CDK1/Cyclin B complex, allowing telomere re-capping before entry into mitosis. This mechanism protects telomere integrity by the maintenance of a cell cycle stage conducive for capping reactions and thereby prevents genomic instability induced by telomere dysfunction. Finally, I studied the cellular functions of 3 poorly characterised shelterin components, TRF1, RAP1 and TPP1, in telomere protection. TRF1 and to a lesser extent RAP1 were shown to be important for telomere protection by suppressing DDR at the telomeres, while TPP1 was shown to be mainly responsible for the recruitment of the catalytic subunit of telomerase, TERT , to the chromatin, contributing to telomere maintenance. In conclusion, my work on both human and mouse models, reveals an important part of the DDR pathways activated by dysfunctional telomeres, as well as the molecular mechanisms underlying the cell cycle specific regulation of telomere capping, which ensures that only cells with intact telomeres enter mitosis.
|
3 |
BMP4 activates MAPK/ERK signaling pathway to increase tumor cell proliferation and migration of hepatocellular carcinomaChiu, Chiang-Yen 22 June 2011 (has links)
Hepatocarcinoma cancer (HCC) is one the most common visceral malignancies in Taiwan, which has a very high incidence and a devastatingly poor prognosis. BMP4, belonging to the TGF-£] super-family of proteins is a multifunctional cytokine, known to exert its biological effects through SMAD and non-SMAD dependent pathways and is also known to be involved in human carcinogenesis. However, the effects of the BMP4 signaling in liver carcinogenesis are not yet clearly defined. In this study, we first demonstrate that BMP4 and its receptor, BMPR1A, are over-expressed in a majority of primary HCC and promote the growth and migration of HCC cell lines in vitro. We also further identify that BMP4 can induce HCC CDK1 and cyclinB1 up-regulation to accelerate cell cycle progression. Our study indicates that the induction of HCC cell proliferation is independent on the SMAD signaling pathway, since Smad4 knockdown of BMP4 induced HCC cell lines still leads to the up-regulation of CDK1 and cyclinB1 expression in HCC. Using MEK kinase selective inhibitors, the induction of CDK1 and cyclinB1 mRNA and protein were shown to be dependent on the activation of MEK/ERK signaling. In vivo xenograft studies confirmed that the BMPR1A- knockdown cells were significantly less tumorigenic than control groups. Taken together, our findings show that the up-regulation of BMP4 and BMPR1A in HCC promote the proliferation and metastasis of HCC cells and that CDK1 and cyclinB1 are important, SMAD-independent molecular targets in BMP4 signaling pathways during the HCC tumorigenesis. We propose here that BMP4 signaling pathways may have potential as new therapeutic targets, in HCC treatment.
|
4 |
Rôle de la déubiquitinase BAP1 dans la réponse cellulaire aux dommages à l'ADNGhram, Mehdi 12 1900 (has links)
L'ubiquitination est une modification post-traductionnelle qui joue un rôle central dans
divers processus biologiques. Elle peut être contrecarrée par les déubiquitinases
(DUBs). "BRCA1-Associated Protein 1" (BAP1) est une déubiquitinase, qui fait partie
de complexes multiprotéiques, possèdant une fonction de suppression tumorale ainsi
qu'un potentiel anti-métastatique. De plus, BAP1 est phosphorylée suite aux dommages
à l’ADN par les kinases ATM/ATR.
En nous basant sur ces données, nous avons purifié les protéines associées à BAP1 dans
des conditions de stress génotoxique. Bien que la composition du complexe et l’activité
DUB semblent inchangées, nous avons pu identifier des changements critiques dans les
niveaux et les sites de phosphorylation, confirmant la régulation de BAP1 suite aux
dommages à l’ADN.
En déplétant BAP1 par ARNi et en utilisant des mutants dominants négatifs, nous avons
obtenu des résultats suggèrant que suite au stress génotoxique, cette DUB est requise
pour prolonger le point de contrôle en G2/M et ce, en retardant la reprise du cycle
cellulaire. D'un autre côté, l'expression de BAP1 dans des cellules cancéreuses qui en
sont déficientes restore une ploïdie normale et diminue la fréquence d'aberrations
nucléaires, suggérant que cette protéine joue un rôle dans la stabilité génomique.
Nos résultats suggèrent fortement que BAP1 joue un rôle dans la réponse des cellules au
stress génotoxique et la stabilité génomique. Nos travaux permettront ainsi d’identifier
et de caractériser les voies de signalisation cellulaire régulant l’activité et la fonction de
BAP1 durant les périodes d’exposition à des agents qui endommagent l’ADN. Les
connaissances acquises seront donc d’une valeur tangible pour nôtre compréhension de
la mutagenèse induite par des agents carcinogènes, un déterminant clé de la formation
des tumeurs. / Ubiquitination is a reversible, covalent post-translational modification that regulates
protein function and as such plays crucial roles in a wide range of physiological
processes. Importantly, gain- or loss-of-function mutations in components of the
ubiquitin system have been causally linked to tumorigenesis. The reverse reaction of
ubiquitination is catalyzed by deubiquitinases (DUBs), a family of enzymes that
removes ubiquitin from proteins.
BRCA1-Associated Protein 1 (BAP1) is a deubiquitinase known to be a tumor
suppressor and anti-metastatic protein since deletions and rearrangements are observed
in a wide range of tumors. However, little is known about how BAP1 works into the
cells. Here, we show that BAP1 is hyperphosphorylated after DNA damage by gamma
radiations and ultraviolet light, probably by ATM and/or ATR. Moreover, we found that
BAP1 depletion cause a defect in the maintenance of the G2/M checkpoint after gamma
radiation, suggesting that BAP1 is required to maintain the arrest after DNA damage.
This delay is important to allow DNA repair and to prevent genomic instability.
Consistently, we found that BAP1 expression in BAP1 deficient cells restore normal
diploidy and prevent nuclear aberrations, suggesting that BAP1 links DNA damage
induced checkpoint regulation to genomic stability: two important processes for
carcinogenesis.
These findings provide new insights into the role of deubiquitination in cell signaling
and neoplastic transformation.
|
5 |
Rôle de la déubiquitinase BAP1 dans la réponse cellulaire aux dommages à l'ADNGhram, Mehdi 12 1900 (has links)
L'ubiquitination est une modification post-traductionnelle qui joue un rôle central dans
divers processus biologiques. Elle peut être contrecarrée par les déubiquitinases
(DUBs). "BRCA1-Associated Protein 1" (BAP1) est une déubiquitinase, qui fait partie
de complexes multiprotéiques, possèdant une fonction de suppression tumorale ainsi
qu'un potentiel anti-métastatique. De plus, BAP1 est phosphorylée suite aux dommages
à l’ADN par les kinases ATM/ATR.
En nous basant sur ces données, nous avons purifié les protéines associées à BAP1 dans
des conditions de stress génotoxique. Bien que la composition du complexe et l’activité
DUB semblent inchangées, nous avons pu identifier des changements critiques dans les
niveaux et les sites de phosphorylation, confirmant la régulation de BAP1 suite aux
dommages à l’ADN.
En déplétant BAP1 par ARNi et en utilisant des mutants dominants négatifs, nous avons
obtenu des résultats suggèrant que suite au stress génotoxique, cette DUB est requise
pour prolonger le point de contrôle en G2/M et ce, en retardant la reprise du cycle
cellulaire. D'un autre côté, l'expression de BAP1 dans des cellules cancéreuses qui en
sont déficientes restore une ploïdie normale et diminue la fréquence d'aberrations
nucléaires, suggérant que cette protéine joue un rôle dans la stabilité génomique.
Nos résultats suggèrent fortement que BAP1 joue un rôle dans la réponse des cellules au
stress génotoxique et la stabilité génomique. Nos travaux permettront ainsi d’identifier
et de caractériser les voies de signalisation cellulaire régulant l’activité et la fonction de
BAP1 durant les périodes d’exposition à des agents qui endommagent l’ADN. Les
connaissances acquises seront donc d’une valeur tangible pour nôtre compréhension de
la mutagenèse induite par des agents carcinogènes, un déterminant clé de la formation
des tumeurs. / Ubiquitination is a reversible, covalent post-translational modification that regulates
protein function and as such plays crucial roles in a wide range of physiological
processes. Importantly, gain- or loss-of-function mutations in components of the
ubiquitin system have been causally linked to tumorigenesis. The reverse reaction of
ubiquitination is catalyzed by deubiquitinases (DUBs), a family of enzymes that
removes ubiquitin from proteins.
BRCA1-Associated Protein 1 (BAP1) is a deubiquitinase known to be a tumor
suppressor and anti-metastatic protein since deletions and rearrangements are observed
in a wide range of tumors. However, little is known about how BAP1 works into the
cells. Here, we show that BAP1 is hyperphosphorylated after DNA damage by gamma
radiations and ultraviolet light, probably by ATM and/or ATR. Moreover, we found that
BAP1 depletion cause a defect in the maintenance of the G2/M checkpoint after gamma
radiation, suggesting that BAP1 is required to maintain the arrest after DNA damage.
This delay is important to allow DNA repair and to prevent genomic instability.
Consistently, we found that BAP1 expression in BAP1 deficient cells restore normal
diploidy and prevent nuclear aberrations, suggesting that BAP1 links DNA damage
induced checkpoint regulation to genomic stability: two important processes for
carcinogenesis.
These findings provide new insights into the role of deubiquitination in cell signaling
and neoplastic transformation.
|
6 |
Mécanisme de la dérégulation du cycle cellulaire de l'hôte par Staphylococcus aureus / Méchanisms of regulation of the host cell cycle by Staphylococcus aureusEl Aour Filho, Rachid Aref 03 November 2016 (has links)
Staphylococcus aureus est une bactérie Gram positive qui colonise la peau des animaux et des humains sains. Dans certaines conditions, telles que la perturbation du microbiote, S. aureus peut induire différentes maladies en déjouant les fonctions de défenses de la cellule hôte. Récemment, notre équipe a montré que les S. aureus méthiciline-résistant (MRSA) souche MW2 (USA400) étaient capables d’induire un retard de la transition de phase G2/M des cellules HeLa. Dans ce travail, nous avons démontré que cette action est initiée par des composants du surnagent de culture de S. aureus.Différentes fractions de surnagents de culture de MW2 ont été obtenues par la chromatographie d’exclusion et analysées par la spectrométrie de masse. Ces techniques nous ont permis d’identifier les peptides phenol-soluble modulins alpha (PSMa) comme responsables du retard du cycle cellulaire des cellules hôtes. Confirmant l’implication de ces modulines, la souche LAC¿psma déficiente en PSMa 1 – 4, n’a pas affecté la progression normale du cyle cellulaire de cellules epitheliales HeLa. De plus, le traitement de ces cellules avec des PSMa1 et PSMa3 synthétiques a induit un retard de la transition de phase G2/M qui a été associé à la diminution de l’expression de gènes codant des défensines ß. Enfin, nous avons démontré que la souche MW2 diminue le niveau d’optineurine et d’optineurine phosphorylée sur la sérine-177, une protéine hôte qui est impliquée dans la transition de phase G2/M. Ce travail représente une étape importante de la compréhension du mécanisme d’interférence de S. aureus / Staphylococcus aureus is a Gram-positive bacterium that colonizes the skin of healthy animals and humans. In certain conditions, including the disruption of the commensal microbiota, S aureus can cause different diseases by deviating the host defense functions. Recently, our group has shown that the methicillin-resistant S. aureus (MRSA) MW2 (USA400) strain causes delay in the transition of the G2/M phase of HeLa cells. In the present work, we demonstrated that this action is initiated by components of the supernatant of the S. aureus culture. Different supernatant fractions were obtained by size exclusion chromatography and were analyzed by mass spectrometry, which allowed to identify phenol-soluble modulins alpha (PSMa) as responsible for the host cell cycle delay.Confirming the involvement of these modulins in the delay, the MRSA LAC¿psma strain, which is deficient in PSMa1–4, did not affect the normal progression of the cycle in HeLa cells. In addition, the treatment of these cells with synthetic PSMa1 and PSMa3 caused delay in the transition of the G2/M phase associated with the decreased production of host ß-defensins. Lastly, we demonstrated that the MW2 strain, which produce PSMa, decreases the level of optineurin and optineurin phosphorylated at serine 177, a host protein that is involved in the G2/M phase transition. The work conducted in this thesis represents an important achievement in the understanding of how S. aureus interferes with the host cell cycle, revealing a new role for PSMa produced by this bacterium.
|
7 |
Molecular Mechanism of Vitamin D Action and its Implications in Ovarian Cancer Prevention and TherapyJiang, Feng 01 May 2004 (has links)
1,25-dihydroxyvitamin D3 (1,25VD), the active form of vitamin D (VD), suppresses the growth of numerous human cancer cell lines by inhibiting cell cycle progression and inducing cell death. Genes that mediate each of these activities remain largely unidentified and there are no preclinical data for 1,25VD analogues in ovarian cancer (OCa). We hypothesize that 1,25VD and its analogues inhibit the development of OCa. In this study, we demonstrated, (a) 1,25VD causes cell cycle arrest at the G1/S and G2/M transition and induces apoptosis in OCa cells. (b) We also found that gadd45 is one of primary target genes for 1,25VD-mediated G2/M arrest. A direct repeat 3 (DR3) vitamin D response element (VDRE) is identified in the fourth exon of gadd45. This exonic VDRE forms a complex with the vitamin D receptor (VDR)/retinoid X receptor (RXR) heterodimer in vitro and mediates the induction of reporter activity by 1,25VD in vivo. VDR is recruited in a ligand-dependent manner to the exonic enhancer but not to the gadd45 promoter regions. In OCa cells expressing GADD45 anti-sense cDNA or GADD45-null mouse embryo fibroblasts, 1,25VD fails to induce G2/M arrest, suggesting that G2/M arrest induced by 1,25VD is mediated through GADD45. Further study showed that GADD45 mediates the effect of 1,25VD by decreasing cdc2 kinase activity. (c) hTERT, the catalytic subunit of telomerase, is identified as a primary target for 1,25VD. 1,25VD decreases telomerase activity and hTERT mRNA expression. The down-regulation of hTERT mRNA is due to decreased mRNA stability by 1,25VD, rather than decreased transcription of hTERT through VDRE. Clones stably transfected with hTERT showed higher telomerase activity and longer telomere length than parental cells. Moreover, hTERT clones resist 1,25VD-induced apoptosis and growth inhibition. In contrast to parental cells which do not recover from prolonged treatment with 1,25VD, hTERT clones re-grew rapidly after 1,25VD withdrawal. (d) We demonstrated that the 1,25VD analogue EB1089 inhibits OCa cells in vitro and OCa xenograft in vivo without inducing hypercalcemia. We also demonstrated precursors for epithelial OCa express VDR and human primary ovarian surface epithelial cells respond to 1,25VD. Taken together, these results strongly suggest that 1,25VD analogues may be effective in the chemoprevention and chemotherapy of OCa.
|
8 |
A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice / RUNXを標的とした遺伝子スイッチオフ法はBIRC5/PIF1-p21経路を介してマウスの膠芽腫の増殖を抑制するYamamoto(Hattori), Etsuko 23 March 2023 (has links)
京都大学 / 新制・課程博士 / 博士(医学) / 甲第24511号 / 医博第4953号 / 新制||医||1064(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 伊藤 貴浩, 教授 岩田 想, 教授 河本 宏 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM
|
9 |
APOBEC3B is preferentially expressed at the G2/M phase of cell cycle. / APOBEC3Bは細胞周期のG2/M期に高発現するHirabayashi, Shigeki 24 May 2021 (has links)
京都大学 / 新制・課程博士 / 博士(医学) / 甲第23382号 / 医博第4751号 / 新制||医||1052(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 伊藤 貴浩, 教授 滝田 順子, 教授 江藤 浩之 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM
|
10 |
The implication of Kv10.1 in the regulation of G2/M progressionMovsisyan, Naira 16 May 2019 (has links)
No description available.
|
Page generated in 0.0602 seconds